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FACTORS THAT INFLUENCE PARTICIPATION IN PHYSICAL ACTIVITY IN 
ADULTS WITH NONALCOHOLIC FATTY LIVER DISEASE 
by 
MACY MOSHER 
Nonalcoholic fatty liver disease (NAFLD) is a progressive spectrum of disorders 
leading to hepatic steatosis is present with no secondary cause of liver disease.  NAFLD 
is one of the leading cause of chronic liver disease in the United States and the prevalence 
of this chronic disease is increasing globally.  Despite advances in science and treatment, 
providers rely on lifestyle choices and emphasis on physical activity as a main 
component of the treatment plan for NAFLD. Physical activity has been well documented 
in improving liver function tests and reduces the level of intrahepatic adipose tissue. 
Despite the known benefit, persons with NAFLD do not consistently participate in PA. 
To date, there are no known studies examining factors that influence level of physical 
activity in those with NAFLD. The purpose of this study was to examine fatigue, 
depression, perceived illness severity, exercise-self efficacy, and exercise benefits and 
barriers as potential factors that may predict level of physical activity in individuals with 
NAFLD. A cross-sectional, predictive, correlational study was performed.  Ninety-eight 
study participants were recruited from a hepatology clinic in Atlanta, Georgia and data 
were analyzed to examine predictors of physical activity.  Exercise benefits and barriers 
were found to be significant predictors of level of physical activity in those with NAFLD.  
Additionally, exercise self-efficacy demonstrated a mediator effect on the relationship 
between exercise benefits and physical activity.  Overall, this research study further 
vii 
 
advances the understanding of symptom burden associated with NAFLD and factors that 
may influence level of physical activity.
viii 
 
FACTORS THAT INFLUENCE PARTICIPATION IN PHYSICAL ACTIVITY IN 







Presented in Partial Fulfillment of Requirements for the  
Degree of Doctor of Philosophy in Nursing in the Byrdine F. Lewis  
College of Nursing and Health Professions  






































“I praise you because I am fearfully and wonderfully made; your works are wonderful, I 
know that full well.” 
Psalm 139:14 
This work was made possible by the many mentors, leaders, and clinicians that 
have shown me what it is like to be a successful scientist working to improve the lives of 
others. I would like to thank Dr. Melissa Faulkner for her steadfast guidance through this 
process.  I will forever be thankful for your time, experience, knowledge, and dedication. 
I am truly grateful for your guidance not only through this extensive dissertation process 
but also throughout the doctoral program.  I would also like to thank Dr. Mei-Lan Chen 
and Dr. Rahul Maheshwari for serving as my dissertation committee members.  The 
mentorship that you have each provided me is something that I do not take for granted.  
Thank you both for spending your time helping to guide me in this experience. I would 
like to express my gratitude to Dr. Melissa Osborne for her time and patience in statistical 
mentoring. To Natasha and Janelle, thank you for always pointing me in the right 
direction.  I would also like to thank the patients at the Piedmont Transplant Hepatology 
Clinic for their time, sacrifice, and sharing of their unique stories. 
To my parents, thank you for instilling in me the true value of persistence, 
patience, and commitment for without these I would not know success.  Dad, thank you 
for teaching me to stay positive, work hard, and make it happen. Mom, I couldn’t have 
asked for a better role model.  Your strength, faith, and leadership are unmatched.  You 
are the reason that I chose to become a nurse and your encouragement has pushed me to 
the finish line. 
xi 
 
To my Cody, what else is there to say but we made it!  Thank you for helping me 
navigate through this journey. I can’t imagine having anyone else by my side.  Thank you 
for always supporting my crazy dreams, inspiring me to be a better version of myself, and 
pushing me to never stop. I would not be where I am today without your love and 
support. When I first decided to pursue this doctoral program, little did we know that it 
would be during a global pandemic.  Thank you for not allowing me to give up and to 
just keeping going! This dissertation is dedicated to you and Hattie. 
Hattie Jude, may this be an example that the possibilities in life are endless.  
There are three goals in life 1) always be kind, 2) strive to push boundaries to leave this 
Earth better than when you started, and 3) faith and family above all else.  Hattie, thank 
you for making me a mama.  Mama is a title that I have wanted all of my life.  True to 
our usual fashion, not only were we faced with navigating a global pandemic, a 
dissertation, and a full-time career but we added in a pregnancy and delivery of the most 
beautiful gift all at the same time. What a time to be alive! The gift of motherhood has 
undoubtedly been the biggest blessing in my life and I strive every day to make you 
proud.   
 
















TABLE OF CONTENTS 
 
Section              Page 
 
List of Tables ................................................................................................................ xvi 
 
List of Figures .............................................................................................................. xvii 
 




I. INTRODUCTION ..................................................................................................  1 
 
 Significance of NAFLD .........................................................................................  1 
 
 Background of the Problem ....................................................................................  4 
 
 Statement of Purpose ..............................................................................................  5 
 
 Study Design and Specific Aims ............................................................................  6 
 
 Theoretical Framework ..........................................................................................  6 
 
 Summary ...............................................................................................................  10 
 
II. REVIEW OF THE LITERATURE ......................................................................  12 
 
 Physical Activity ..................................................................................................  12 
 
 Fatigue ..................................................................................................................  13 
 
 Depression ............................................................................................................  14 
 
 Perceived Illness Severity .....................................................................................  16 
 
 Benefits/Barriers ...................................................................................................  17 
 
 Self-Efficacy .........................................................................................................  18 
 





Section               Page 
 
III. STUDY METHODOLOGY .................................................................................  21 
 
 Study Methodology ..............................................................................................  21 
 
  Setting ..........................................................................................................  21 
 
  Sample .........................................................................................................  22 
 
  Sample Size .................................................................................................  22 
 
  Protection of Human Subjects .....................................................................  22 
 
 Procedures ............................................................................................................  24 
 
 Instruments ...........................................................................................................  24 
 
  PROMIS Depression Scale ..........................................................................  24 
 
  PROMIS Fatigue Scale ................................................................................  26 
 
  Exercise Benefits/Barriers Scale .................................................................  28 
 
  Brief Illness Perception Questionnaire ........................................................  29 
 
  Exercise Self-Efficacy Scale .......................................................................  30 
 
  Concise Physical Activity Questionnaire ....................................................  31 
 
  Demographic Intake Form ...........................................................................  32 
 
 Data Analysis ........................................................................................................  33 
 
 Summary ...............................................................................................................  33 
 
IV. STUDY RESULTS ..............................................................................................  35 
 
 Study Results ........................................................................................................  35 
 
 Description of Study Sample ................................................................................  36 
 
 Reliability of Study Instruments ...........................................................................  38 
 




Section               Page 
 
  Descriptive Statistics for Major Study Variables ........................................  39 
 
   Depression .......................................................................................  40 
 
   Fatigue .............................................................................................  40 
 
   Exercise Self-Efficacy .....................................................................  41 
 
   Illness Perception .............................................................................  42 
 
   Physical Activity .............................................................................  42 
 
  Research Question One ...............................................................................  43 
 
  Research Question Two ...............................................................................  45 
 
 Summary ...............................................................................................................  47 
 
V. DISCUSSION AND CONCLUSIONS ................................................................  49 
 
 Fatigue and Depression ........................................................................................  50 
 
 Perceived Illness Severity .....................................................................................  51 
 
 Factors Predicting Level of Physical Activity ......................................................  51 
 
 Exercise Self Efficacy as a Potential Mediator of Exercise Benefits to  
 Physical Activity ..................................................................................................  52 
 
 Relationship to Theory .........................................................................................  53 
 
 Limitations of Study .............................................................................................  54 
 
 Strengths of Study ................................................................................................  55 
 
 Implications of Findings on Clinical Practice ......................................................  56 
 
 Recommendations for Future Research ................................................................  56 
 
 Study Summary ....................................................................................................  57 
 





Section               Page 
 
APPENDICES ................................................................................................................ 76 
  
 APPENDIX A:  Nonalcoholic Fatty Liver Disease and Factors Influencing 
 Physical Activity Demographic Intake Form .......................................................  76 
 
 APPENDIX B:  Fatigue – Short Form 8a ............................................................  78 
 
 APPENDIX C:  Emotional Distress – Depression – Short Form 8a ....................  80 
 
 APPENDIX D:  Exercise Benefits/Barriers Scale ................................................  82 
 
 APPENDIX E:  Concise Physical Activity Questionnaire CPAQ .......................  85 
 
 APPENDIX F:  Brief Illness Perception Questionnaire .......................................  87 
 





LIST OF TABLES 
 
Table                Page 
 
1. Study Participant Demographics ..........................................................................  37 
 
2. Health Demographics for Study Participants ........................................................ 38  
 
3. Internal Consistency of Study Instruments ............................................................ 39  
 
4. Descriptive Statistics of Study Variables .............................................................. 40  
 
5. Correlational Data for All Major Study Variables ................................................ 43  
 
6. Multicollinearity Diagnostics ................................................................................ 44  
 
7. Linear Regression Model Summary ...................................................................... 44  
 
8. Model Coefficients ................................................................................................ 45  
 
9. Indirect Effect of Self-Efficacy on Exercise Barrier and Physical Activity .......... 46  
 





LIST OF FIGURES 
 
Table               Page 
 
1. The Modified Health Belief Model (Rosenstock, 1974) for physical activity 
 in individuals with nonalcoholic fatty liver disease ...............................................  8 
 
2. Study Participant Screening, Eligibility and Inclusion .......................................... 36  
 
3. Mediation Model for Exercise Barriers, Exercise Self-Efficacy, and Physical 
 Activity .................................................................................................................. 46  
 
4. Mediation Model for Exercise Benefits, Exercise Self-Efficacy, and Physical 





LIST OF ABBREVIATIONS 
 
 
NAFLD  Nonalcoholic Fatty Liver Disease 
PA   Physical Activity 
HBM   Health Belief Model 
PROMIS  Patient-Reported Outcomes Measurement Information System 
EBBS   Exercise Benefits/Barriers Scale 
Brief IPQ   Brief Illness Perception Questionnaire 
ESES   Exercise Self-Efficacy Scale 






Nonalcoholic fatty liver disease (NAFLD) is a growing phenomenon globally and 
is associated with other chronic comorbidities. This chronic condition has many negative 
disease outcomes including worsening of comorbid metabolic disorders. Treatment 
guidelines have evolved to include an emphasis on lifestyle modifications. Individuals 
with NAFLD are tasked with modifying nutritional habits, increasing levels of physical 
activity, and enhancing weight loss strategies. Despite evidence suggesting that physical 
activity can improve both physiologic and psychological outcomes that are commonly 
associated with NAFLD (Katsagoni et al., 2016; Chalassani et al., 2012; Mlynarsky et al., 
2016) there remains a gap in knowledge regarding determinants that effect participation 
in regular physical activity. This study examined depression, fatigue, benefits/barriers, 
perceived illness severity, and self-efficacy as possible factors that may influence 
physical activity in persons with NAFLD. 
Overview of Nonalcoholic Fatty Liver Disease 
Significance of NAFLD 
 NAFLD is a leading cause of chronic liver disease in the United States and the 
prevalence of this chronic disease is increasing world-wide (Younossi et al., 2016). 
NAFLD is defined as hepatic steatosis in which there are no secondary causes of liver 
disease with no significant alcohol consumption (Chalassani et al., 2012). The threshold 





less than 14 drinks per week in women (Sanyal et al., 2011). The occurrence of NAFLD 
is increasing with an estimated global prevalence of 25% and an estimate prevalence of 
24% in the U.S. (Younossi et al., 2016; Chalassani et al., 2018). Despite the increase in 
estimated prevalence of NAFLD, there remains an under-reporting of this chronic disease 
on death certificates which leads to an international underestimation of NAFLD (Kim  
et al., 2018). Long-term outcomes associated with NAFLD include progressing hepatic 
fibrosis (Chalassani et al., 2018) worsening of metabolic syndrome (Younossi et al., 
2016) cardiovascular disease (Azzam & Malnick, 2015) and hepatocellular carcinoma 
(HCC) (Chalassani et al., 2018).   
Physical Activity and NAFLD 
Obesity is estimated to occur in 50% of individuals with NAFLD (Chalassani  
et al., 2012; Harrison et al., 2021). Along with obesity and visceral steatosis that are 
known metabolic risk factors (Chalassani et al., 2012) NAFLD is associated with 
metabolic comorbidities related to obesity such as hypertension, diabetes, insulin 
resistance, and hyperlipidemia (Chalassani et al., 2018; Younossi et al., 2012). Lifestyle 
modifications such as diet, physical activity, and weight loss are included in the treatment 
guidelines for individuals with NAFLD (Chalassani et al., 2018). Physical activity (PA) 
is a main component of treatment of NAFLD and is recommended by the American 
Association for the Study of Liver Diseases (Chalassani et al., 2018).   
A growing amount of evidence suggests that PA improves histologic components 
of NAFLD (Chalassani et al., 2012; Katsagoni et al., 2016). Physical activity is 
associated with decreased visceral adipose tissue (Katsagoni et al., 2016) and a decrease 





Department of Health and Human Services (2018) recommends at least 150 minutes to 
300 minutes of moderate-intensity activity per week or 75 to 150 minutes per week of 
vigorous-intensity aerobic activity per week in the general population. Several small non-
randomized trials have examined the effect of PA on NAFLD and have focused on a 
variety of components of PA including aerobic or resistance training, low, moderate, and 
vigorous intensity, diet modification and PA, and duration and frequency of PA 
(Katsagoni et al., 2016). Out of the 12 studies included in a meta-analysis on the effects 
of exercise on outcomes for individuals with NAFLD (Katsagoni et al., 2016) exercise 
alone in individuals with NAFLD improved serum liver lab results and an emphasis on 
exercise and diet improved both body mass index and waist circumference.  However, 
large randomized controlled trials examining the dose effect of PA in NAFLD are lacking 
(Chalassani et al., 2018).  Currently, there are no universally accepted recommendations 
for dose, frequency, or intensity of PA in individuals with NAFLD.  
The American Association for the Study of Liver Diseases (AASLD) 
acknowledges that moderate-intensity physical activity with weight loss improves hepatic 
steatosis, however, they have not made recommendations on the intensity, duration, or 
frequency of physical activity (Chalassani et al., 2018). The Korean Association for the 
Study of the Liver (KASL) guidelines recommend exercising for at least thirty minutes 
twice per week to reduce the lipid-associated inflammation of the liver (KASL, 2013). 
The European Association for the Study of the Liver (EASL) recommends moderate-
intensity aerobic physical activity to total 150-200 minutes per week in addition to 





individually tailored based on health status, preference, and clinical characteristics 
(EASL, 2015). 
Background of the Problem 
 Despite the evidence to support the benefit of PA on outcomes related to NAFLD, 
individuals with NAFLD do not consistently participate in PA. Fifty-four percent of 
individuals with NAFLD reported an activity level of inactive and 57% of those who 
reported being inactive did not spending any time in recreational activities (Kistler et al., 
2011). Additionally, in a self-reported analysis, only 20% of individuals with mild and 
moderate steatosis related to NAFLD reported meeting the Surgeon General’s report 
guidelines for PA (Krasnoff et al., 2008).  It is estimated that about one-half of U.S. 
adults in the general population are meeting recommendations for physical activity to 
prevent chronic disease (CDC, 2019). The benefits of PA include lowering blood 
pressure, reducing risk of stroke and cardiovascular disease, improving mental health, 
and preventing weight gain (CDC, 2019). 
 Increasing PA in individuals with NAFLD can be beneficial. However, there 
remains a gap in the evidence of factors influencing the decision to participate in PA in 
this chronic disease population. Barriers and benefits for regular PA in individuals with 
NAFLD should be considered to enhance participation in PA and improve outcomes. 
Determining perceived benefits and barriers to PA should be used in developing 
interventions that will be most effective to improve PA levels in individuals with 
NAFLD. 
 Previously documented barriers to PA in other populations of chronic illness 





2015; Egerton et al., 2016; Veldjuijzen van Zanten et al., 2015) and depression 
(Roshanaei-Moghaddam et al., 2009). Individuals with NAFLD are at a higher risk of 
significant depression (Bianchi et al., 2005) and fatigue (Assimakopoulos et al., 2018) 
which may impact the decision to participate in PA. Perceived benefits of PA in 
individuals with a chronic illness include improvement in mood, decrease in fatigue, 
overall improvement in body functioning, and improvement in overall health (Rehm & 
Konkle-Parker, 2016).   
In addition to psychosocial factors and benefits/barriers, exercise self-efficacy and 
perceived illness severity may impact the decision to participate in PA in individuals with 
NAFLD. Enhancing self-efficacy has demonstrated a positive association with impacting 
the decision to participate in PA (Klompstra et al., 2018; Veldjuijzen van Zanten et al., 
2016). The individual’s perception of the severity of illness may also impact levels of PA. 
In a study of individuals with chronic lung disease, a higher perceived severity of illness 
correlated with a reduced level of PA (Zoeckler et al., 2014). Psychosocial variables, 
benefit/barriers, exercise self-efficacy, and perceived severity of illness were examined in 
the current study to determine their effect on levels of PA participation. 
Statement of Purpose 
 Although evidence suggests that PA improves the physiologic impact of NAFLD 
and is now considered part of the treatment guidelines, no studies were found that 
discussed factors associated with PA in individuals with NAFLD. Through exploring 
similar factors that have been associated with participating in PA in other population of 





Moghaddam et al., 2009) self-efficacy (Veldjiuijzen van Zanten et al., 2016) and 
perceived severity of illness (Zoeckler et al., 2014).   
The purpose of this study is to gain an understanding of their impact, as well as 
benefits and barriers on PA participation in individuals with NAFLD. The potential 
mediating effect of self-efficacy on the relationships between benefits or barriers and PA 
was also be examined.  Information obtained in this research will inform the development 
of targeted innovative interventional strategies to improve PA in this population. 
Study Design and Specific Aims 
 A cross-sectional, correlational study design was used to gain a more 
comprehensive understanding of key factors that influence current participation in PA by 
individuals with NAFLD. The possible effect of exercise self-efficacy on perceptions of 
benefits or barriers to current level of physical activity was also examined.  Accordingly, 
the following research questions were investigated in individuals with NAFLD. 
1) Do symptoms of fatigue or depression, perceptions of level of illness severity or 
benefits and barriers to physical activity predict the amount of self-reported 
physical activity? 
2) Does exercise self-efficacy mediate the relationship between perceptions of 
benefits or barriers for physical activity and self-report physical activity? 
Theoretical Framework 
 This study was guided by the Health Belief Model (HBM), a well-established 
theory that grew out of a group of independent concepts of public health interest in the 
U.S. between the 1950’s and 1960’s (Rosenstock, 1974). The HBM is an expectancy 





of disease, the evaluated benefit of the proposed health action, and an internal or external 
stimulus that triggers the individual to participate in the appropriate health behavior 
(Maiman & Becker, 1974). The HBM is one of the most widely used theoretical 
frameworks in understanding health behaviors (Painter et al., 2008). The five major 
theoretical concepts of the HBM include: 1) perceived severity, 2) perceived 
susceptibility, 3) perceived benefits/barriers, 4) cues to action, and 5) self-efficacy. 
 The HBM examines an individual’s assessment to engage in a health behavior and 
is based on the perspective of the individual (Maiman & Becker, 1974). The HBM 
theorizes that in order for an individual to decide to participate in the health behavior, 
they must feel as though they are vulnerable to the health condition that would impact 
their individual quality of life (Rosenstock, 1974). The HBM can be summarized into 
three main components which include 1) perceived severity or threat of the health 
condition, 2) modifiable risk factors such as psychosocial, structural, and triggers, and 3) 















Figure 1: The modified Health Belief Model (Rosenstock, 1974) for physical activity in 














 Perceived threat is a major theoretical concept of the HBM that can be described 
as the individual’s perception of the threat, susceptibly, and severity of the disease 
(Rosenstock, 1974). The perceived threat is subjective and varies based on the 
individual’s perception of the risk of disease (Rosenstock, 1974). In individuals with 
NAFLD, their perceived threat of this disease process may vary based on 
symptomatology, severity of disease, other comorbidities, and knowledge of the disease 























with perceived illness (Mlynarsky et al., 2016). This may indicate that an individual does 
not have a significant perceived threat of NAFLD and thus may choose not to participate 
in PA. This study assessed perceived severity of NAFLD with the HBM theoretical 
framework to determine its relationship to level of PA.  
Modifiable Risk Factors 
 The HBM framework includes sociopsychological and structural variables and 
aims to examine the relationship between these variables and the decision to engage in 
the proposed health behavior. The current study examined depression and fatigue as two 
sociopsychological variables that may impact the decision to participate in PA. These 
variables were included due to the documented increase in risk for depression and fatigue 
in individuals with NAFLD (Assimakopoulos et al., 2018; Bianchi et al., 2005). 
Additionally, fatigue and depression are both considered modifiable and have previously 
demonstrated a correlation with reduced activity levels in other populations (Egerton  
et al., 2016; Roshanaei-Moghaddam et al., 2009). 
 Self-efficacy is theorized as an individual’s belief that they are able to implement 
the proposed health behavior (Bandura, 1977). Self-efficacy was examined in this 
proposed study as a mediator variable that may impact the relationship between perceived 
benefit/barriers of PA and participation in PA. An increased perceived self-efficacy has 
been correlated with an increased level of PA (Mo et al., 2011). Lastly, perceived benefits 
and barriers to participation in PA were measured to determine the effect of these 
variables on participation in PA, the targeted health behavior and study outcome. 





associated with NAFLD and the current evidence that individuals with NAFLD are not 
physically active. 
Application of the HBM to NAFLD 
 The HBM was originally developed to understand behaviors in regards to 
prevention of chronic illness (Champion, 1984) however, the application of HBM to 
understand secondary health prevention behaviors has evolved to include studies about 
PA (Mo et al., 2016), infectious disease practices (Padchasuwan et al., 2016), nutrition 
behavior (Jeong & Ham, 2018; Kim et al., 2012) dental hygiene (Lee et al., 2018), 
medication adherence (Obirikorang et al., 2018) and substance use (Mona et al., 2014). 
Additionally, the HBM has been studied in many populations of chronic illness including 
congestive heart failure (Baghianimoghadam et al., 2013) osteoarthritis (Ang et al., 2008) 
hypertension (Obirikorang et al., 2018) and diabetes mellitus (Koch, 2002). The HBM 
has been applied and critiqued in a variety of populations and health behaviors and has 
been well documented in research focusing on PA. The application of the HBM aided in 
explaining factors that affected a significant increase in PA (Hoseini et al., 2014). Based 
upon the strong evidence of the applicability of the HBM to health behaviors in persons 
with chronic illnesses, the model is well justified to guide the examination of the possible 
relationships of the variables of interest in this proposed investigation (see Figure 1). 
Summary 
This study examined the modifiable factors of perception of fatigue, depression, 
illness severity and benefits or barriers for engaging in physical activity, as well as the 
mediating effect of self-efficacy between benefits or barriers and PA.  A better 





enhancing this lifestyle modification, impact therapeutic strategies, and improve overall 
health status of this chronic disease population. This proposal provides valuable resources 






REVIEW OF THE LITERATURE 
 The goal of this study was to examine the factors that influence participation in 
physical activity (PA) in individuals with non-alcoholic fatty liver disease (NAFLD). 
This chapter contains a review of the literature related to the Health Belief Model as a 
theoretical framework selected to guide this study examining fatigue, depression, 
benefits/barriers, perceived severity, and self-efficacy and the impact of these factors on 
self-reported level of PA. The Cumulative Index to Nursing & Allied Health Literature 
(CINAHL), PubMed, Medline, and ProQuest databases were used to conduct this review.  
Numerous search terms were used in this review including: NAFLD, physical, fatigue, 
depression, benefits, barriers, perceived severity, Health Belief Model, and self-efficacy. 
Physical Activity 
 Current treatment guidelines for the management of NAFLD include 
recommendations for diet modifications, PA, and weight loss (Chalassani et al., 2018). 
Physical activity is a major component of management and prevention of NAFLD. 
Physical activity has demonstrated an improvement in the histological components of 
NAFLD, however, there are no universal recommendations for dose, frequency, or 
intensity of PA in individuals with NAFLD. Despite the guidelines emphasizing the 
importance of PA in treatment of NAFLD, only 20% of individuals with NAFLD 
reported being active (Krasnoff et al., 2018). When compared with a healthy control 





walked 18% fewer steps per day (Hallsworth et al., 2015). This study aimed to examine 
constructs established in the theoretical foundation of the health belief model that impact 
participation in PA in individuals with NAFLD.  
Factors Associated with Physical Activity 
Fatigue 
 The concept of fatigue is dynamic and complex and there is not a standardized 
definition (Engberg et al., 2017). Lower levels of fatigue have been traditionally reported 
in individuals who self-reported better overall health (Egerton et al., 2017). Despite the 
wide array of methods used to assess fatigue, there is no universally accepted 
methodology (Engberg et al., 2017).  The estimated prevalence of fatigue in the U.S. 
workforce is 37.9% and is found to be significantly higher in individuals who reported 
two or more health conditions (Ricci et al., 2007). In populations of chronic illness, 
fatigue is a commonly reported symptom.  For example, 68% of individuals with diabetes 
mellitus reported having fatigue (Jain et al., 2015). Fatigue was reported in 52.5% of 
individuals with thyroid cancer and was inversely correlated with level of PA (r=.265, 
p<.001) (Alhashemi et al., 2017). Additionally, feelings of fatigue were reported in 67% 
of surveyed adults with chronic congestive heart failure in addition to impairments in 
level of activity (Kraai et al., 2016). Fatigue is a common barrier to PA and was reported 
by 13% of individuals with colorectal cancer (Fisher et al., 2016). 
Fatigue was correlated with lower levels of PA in an international group of adults 
and those with significant fatigue were associated with 1,150 less steps per day, a 17% 
reduction, than those who did not report fatigue (Egerton et al., 2016). Fatigue was also 





that were obese (Egerton et al., 2016). Participation in leisure activity demonstrated a 
significant association with lower levels of fatigue, and longer times of sitting correlated 
with higher overall fatigue scores (Egerton et al., 2017).  
Similar to findings with persons experiencing other chronic illnesses, fatigue is a 
commonly reported symptom associated with chronic liver disease across etiologies 
including NAFLD (Assimakopoulos et al., 2018; Dwight et al., 2000).  Individuals with 
NAFLD experience a significantly higher level of fatigue when compared with those 
without liver disease (Newton et al., 2008) and this is reported to be a main reason for not 
participating in PA in 12.9% of persons with NAFLD (Mlynarsky et al., 2016).   
The unique physiologic pathway of fatigue in individuals with NAFLD is not 
fully understood. It is hypothesized that the role of the liver in regulating the storage and 
release of energy and the inflammatory mechanisms associated with NAFLD are directly 
related to fatigue in this population (Gerber et al., 2019). Individuals with NAFLD that 
had higher levels of fatigue demonstrated lower levels of activity and more prominent 
somatic symptomatology (Assimakopoulos et al., 2018; Newton et al., 2008). Fatigue 
was inversely correlated with steps per day in individuals with NAFLD compared to 
those without NAFLD, and those with NAFLD also took significantly fewer steps per 
day (Newton et al., 2008). Fatigue did not demonstrate a relationship with severity of 
histological markers of NAFLD (Newton et al., 2008) or severity of liver disease (Dwight 
et al., 2000). Physical activity with weight loss demonstrated an improvement in fatigue 







 Fatigue and depression frequently co-exist in individuals with chronic liver 
disease (Dwight et al., 2000). Individuals with chronic illness, such as liver disease, are at 
a higher risk of significant depression and the severity of their depression commonly 
impacts their level of PA. In persons with depression, every one-point increase as 
measured by depression in the Montgomery-Asberg Depression Rating Scale (MADRS) 
(Montgomery & Asberg, 1979) is reported to have a 2.4-minute reduction in average 
activity measured via accelerometer (Helgadottir et al., 2015). Higher levels of 
depression are found to be negatively associated with time spent in physical activity in 
persons with other chronic disease, such as heart failure (Haedtke et al., 2017) and cancer 
(Liu et al., 2017).    
In other research examining depression and PA, persons with chronic pulmonary 
disease that reported meeting PA guidelines were less likely to have major depression 
than those who did not meet PA guidelines (OR =.41, 95%, CI: 0.18-0.94) (Loprinzi  
et al., 2013). Interestingly, PA was inversely related to depression in a dose-response 
manner (Loprinzi et al., 2013). This may suggest that the amount or dose of PA may 
serve as an intervention to improve overall depression. The positive effect of PA as an 
intervention for depression was also evident in populations with chronic illness including 
arthritis (Kelley et al., 2015), systemic lupus erythematosus (O’Dwyer et al., 2017) and 
myeloproliferative neoplasms (Eckert et al., 2017). However, there is a paucity of 
research that examines the effect of depression severity on the level of PA in individuals 





Of particular concern is the prevalence of depression in persons with chronic liver 
disease that are 2.2 times more likely to have major depression when compared with the 
general population (Bianchi et al., 2005). Depression has been independently associated 
with a diagnosis of NAFLD (Elwing et al., 2006). In a sample of 156 participants with 
mixed liver disease etiology, 56.7% of the participants had scores that indicated clinical 
depression (Youssef et al., 2013). In a review of a large clinical database of individuals 
with NAFLD, 67% of individuals had either clinical or subclinical depression (Weinstein 
et al., 2011).   
Individuals with NAFLD are at a higher risk of depression than those with 
Hepatitis B (Elwing et al., 2006). Adults with NAFLD and comorbid depression are more 
likely to have more severe steatosis (Nardelli et al., 2016; Youssef et al., 2013).  
Individuals with NAFLD and depression are less likely to respond to cardiometabolic risk 
factor reductions strategies and can be resistant to standard treatment (Nardelli et al., 
2016). These issues persist because little is known about the etiology of depression in 
persons with NAFLD and there are no current recommendations for depression 
screenings in this population (Chalasani et al., 2018). Along with depression, research 
indicates NAFLD is associated with an overall decrease in quality of life (Fabregas et al., 
2013; Gallegos-Orzoco et al., 2003; Santos et al., 2012).  The current state of the 
evidence suggests that NAFLD is directly associated with an increased risk of depression.  
Perceived Illness Severity 
Perceived illness severity has a significant impact on adaptation to chronic illness 
and should be considered in research focusing on improvement of chronic health status 





relationship between perceived severity of illness and level of PA (Zoeckler et al., 2014). 
For example, in individuals with rheumatoid arthritis, a higher perceived disease severity 
was found in those with high levels of depression and pain and a lower perceived disease 
severity was associated with good physical function, lower levels of pain, and lower 
depression scores (Groarke et al., 2004).  
In a cross-sectional study, 57.2% of individuals with NAFLD reported not fully 
understanding NAFLD, 53.6% identified NAFLD as a chronic condition, and 60% 
believed that NAFLD is considered a major health concern (Zelber-Sagi et al., 2017). 
Additionally, only 53.4% of individuals with NAFLD reported anticipating a medical 
complication related to NAFLD (Zelber-Sagi et al., 2017). The perceived cause of 
NAFLD varied, however, 6.3% of study participants reported the cause of NAFLD to be 
lack of PA (Zelber-Sagi et al., 2017). These data suggest inconsistent perceptions of the 
seriousness of NAFLD and that those with NAFLD may not perceive a high severity of 
this chronic disease.   
Benefits/Barriers 
An individual’s perception of benefits and barriers to participation in PA may 
influence their participation in consistent activity. Thus, examining the relationship 
between benefits/barriers and level of PA and specific benefits/barriers reported by 
populations of interest may be beneficial in improving activity level. Improving fitness, 
improving overall health, and maintaining or losing weight are commonly reported 
benefits of PA (Fisher et al., 2016). Almost all participants with multiple myeloma 
responded that PA improves overall health and also aided in enjoyment of life and social 





fatigue, motivation, and general body aches in adults with acute leukemia (Bryant et al., 
2017). Individuals with multiple sclerosis reported that the improvement in physical 
performance and feelings of personal accomplishment were the greatest perceived benefit 
of PA and that physical exertion and lack of access to exercise facilities were the greatest 
barriers to (Stroud et al., 2009). Liu et al. (2017) found that the degree of perceived 
benefit of PA was correlated with improvement in level of PA.   
 Age, general musculoskeletal aches, difficulty breathing, and lack of time are 
commonly reported barriers to PA (Fisher et al., 2016). Additional barriers to PA in 
individuals with multiple myeloma included fatigue, pain, low interest in PA, low self-
efficacy, and concern about symptoms of chronic illness and side effect of treatment 
(Craike et al., 2013). Physical symptom burden is also a commonly reported barrier to PA 
(Bryant et al., 2017). Individuals who reported any barrier to PA were significantly less 
likely to participate in PA then those who did not report any barriers (Fisher et al., 2016).   
In individuals with NAFLD, 32.9% reported avoiding PA (Mlynarsky et al., 
2016). Total time spent participating in PA was twice as high in individuals without 
NAFLD when compared to those with NAFLD (Mlynarsky et al., 2016). The most 
common barriers reported in individuals with NAFLD in participating in PA were 
boredom, no available time, and fatigue (Mlynarsky et al., 2016).  
Self-Efficacy 
 Perceived self-efficacy is a major determinant in participation in behavioral 
activities, how much effort will be spent in achieving the activity, and how long the effort 
will be sustained (Bandura, 1977). Individuals tend to avoid situations where they feel 





to participate in an activity they feel they are capable of managing (Bandura, 1977). Self-
efficacy has consistently demonstrated a positive association with level of activity in a 
variety of populations (Blake et al., 2016; Kasser & Komo, 2012; Zelber-Sagi et al., 
2017). Self-efficacy has demonstrated a strong correlation with PA (r=.40, p<.01) and is a 
predictor of the level of PA (Blake et al., 2016; Kasser & Kosmo, 2012). Individuals with 
higher perceived self-efficacy experienced fewer barriers to exercise (Kasser & Kosmo, 
2012). This may indicate that enhanced self-efficacy can help individuals overcome 
barriers to exercise, thus, having higher levels of PA.  
 Limited research has focused on self-efficacy in persons with NAFLD.  In a study 
by Zelber-Sagi and colleagues (2017) they found that a moderate to high level of self-
efficacy was associated with healthy eating habits and a positive perception of treatment 
effectiveness.  However, self-efficacy specific to physical activity was not measured. A 
high perception of self-efficacy may positively influence the commitment to participation 
in PA. Thus, a high perceived self-efficacy may impact the relationship between 
perceived benefits and overall level of PA. Alternatively, a low perceived self-efficacy 
may influence the relationship between perceived barriers and PA.  
Summary 
 This chapter provided an examination of the current state of the literature in 
regards to evidence supporting the use of PA in treatment of NAFLD.  Additionally, the 
Health Belief Model was the guiding theoretical framework for this study due to its 
relevance to the variables of interest, compatibility with current state of the literature, and 
its extensive use in studying factors that may influence participation in PA.  Depression, 





in other chronic health conditions as potential factors influencing PA.  Additionally, 
individuals with NAFLD are at increased risk of these disease symptoms.  Through 
evaluating PA level guided by the constructs of the Health Belief Model researchers may 







A cross-sectional, correlational study design was used to examine the 
relationships among fatigue, depression, illness perception or benefits or barriers on the 
level physical activity (PA) in individuals with nonalcoholic fatty liver disease (NAFLD). 
Additionally, exercise self-efficacy was examined as a potential mediator of the effect of 
exercise benefits or barriers on the level of PA in this population. This chapter includes 
the procedural aspects of this study including subject recruitment, enrollment, consent 
procedures, process for data collection, data management, as well as data analysis.  The 
specific research questions for the study are: 
1) Do symptoms of fatigue or depression, perceptions of level of illness severity 
or benefits and barriers to physical activity predict the amount of self-reported 
physical activity? 
2) Does exercise self-efficacy mediate the relationship between perceptions of 
benefits or barriers for physical activity and self-reported physical activity? 
Setting 
The setting for the study recruitment occurred at the Piedmont Transplant 
Hepatology Clinic in Atlanta, Georgia. This hepatology clinic services patients from all 
over the Southeastern region of the United States that include the states of Georgia, 
Alabama, and South Carolina. The clinic serves patients with a variety of hepatology 






 This study included both female and male participants with NAFLD with equal 
numbers to minimize variability of findings based upon sex. Inclusion criteria includes 
individuals (a) between the ages of 18-75, (b) diagnosed with NAFLD documented by a 
clinical diagnosis and recorded on the medical record, and (c) are able to speak, read and 
write in English.  Exclusion criteria includes (a) other significant medical diagnoses, (b) 
etiology of liver disease other than NAFLD, (c) any previously diagnosed mental health 
disorder, (d) currently taking prescribed medication for depression (or within previous 
three months), (e) active alcohol or substance use (f) mobility limitations (current use of 
walker, cane, or wheelchair), and (g) any person that has been seen in the clinic for less 
than three months. 
Sample Size 
A power analysis was conducted apriori utilizing G*Power (Faul et al., 2009) for 
multiple regression with six predictors, F-squared effect size of .15, alpha of .05, and a 
power of .80 to determine recommended total sample size. The sample sized is estimated 
at 98.  Over-recruitment of study participants was considered to control for possible 
incomplete data sets. The estimated total sample size included 105 participants.  
Protection of Human Subjects 
Prior to data collection, this study proposal was approved by the Georgia State 
University Institutional Review Board and the Piedmont Healthcare Institutional Review 
Board.  Potential study participants were informed of the aims of the study and were 
voluntarily enrolled. Written informed consent and HIPAA authorization forms were 





All participants were notified of their right to withdraw from the study at any point 
without penalty. Information regarding the study was provided to each study participant 
by the investigator. Information regarding the right to confidentiality was provided to 
each study participant. An introductory meeting with each participant was held with the 
primary investigator to complete informed consent, voluntary enrollment and to receive 
information on the right to withdraw and study instructions. Potential study participants 
were assured that their decision to participation in the research study would have no 
impact on their medical care. There were no financial costs to study participants other 
than the use of their time to complete study instruments. 
Due to the design of this research, there were minimal expected risks to study 
participants. The burden of completing study instruments could have led to research 
fatigue and was assessed on an ongoing basis. Additionally, if scores on the PROMIS 
depression scale were indicative of moderate or severe depression, study participants 
were referred for additional treatment.  Collaboration with the Piedmont Healthcare 
psychiatric mental health nurse practitioner was conducted prior to data collection. This 
collaboration served as a point of referral as needed for individuals that scored greater 
than 60 on the PROMIS depression 8a scale. Data were monitored every 48 hours by the 
primary investigator to identify participants that scored above the cutoff score. These 
individuals were referred to the Piedmont psychiatric nurse practitioner for additional 
screening and treatment as needed. This referral to the psychiatric mental health nurse 








Hepatology providers at Piedmont Hepatology Clinic were made aware of the 
proposed research topic, eligible study participants, ineligibility criteria, and were 
provided contact information for the lead nurse researcher. The primary investigator 
made weekly visits to the hepatology clinic to engage with the staff at the clinic to answer 
research-related questions and to screen for potential study participants. 
Data collection occurred at a standard outpatient hepatology clinic appointment.  
Data were collected utilizing printed self-reported study instruments.  Participants were 
provided a private space to complete the study instruments. It is estimated that it took 
each study participant around 25-30 minutes to complete all study instrument items. Prior 
to the self-administration of the instruments, the study participants met briefly with the 
primary investigator to provide instruction on data collection and to answer any research-
related questions. Study participants were asked to self-administer the instruments 
without family or social support input.  Data collected from the study instruments were 
de-identified using study ID numbers for each participant and entered directly into SPSS 
statistical software. 
Instruments 
PROMIS Depression Scale 
 The Patient-Reported Outcomes Measurement Information System (PROMIS) 
depression short form 8a was used to measure depression in this proposed study.  This 
instrument assesses depression through self-reported feelings of sadness, guilt, self-
criticism, worthlessness, loneliness, interpersonal alienation, and loss of interest 





universal implementation and is not disease-specific (PROMIS Health Organization, 
2019a). This PROMIS tool is intended for adults over the age of 18 and assesses 
depression over the past 7-day period (PROMIS Health Organization, 2019a). The short 
form was chosen due to the brevity of administration and participants were instructed to 
answer all of the instrument items. The most recent version, 8a, was chosen due to the 
recommendation by the instrument developers to use the highest or more recent version 
number. 
 The PROMIS depression short form 8a is an 8-item questionnaire with a five-
point Likert response option ranging from “never” to “always” (PROMIS Health 
Organization, 2019a). The raw score on this depression scale ranges from 8-40, with a 
higher score indicating more significant clinical depression (PROMIS Health 
Organization, 2019a). Raw scores can be applied to the score conversion table to 
establish a T-score 
(https://www.healthmeasures.net/images/PROMIS/manuals/PROMIS_Depression_Scorin
g_Manual.pdf). A final score is represented by a T-score which indicates the overall 
standardized score. The T-scores range from 38.2-81.3 and the mean T-score is 50 with a 
standard deviation of 10 (PROMIS Health Organization, 2019a). A T-score less than 55 
is considered normal, 55-60 mild depression, 60-70 moderate depression, and greater 
than 70 is indicative of severe depression (PROMIS Health Organization, 2019a). The 
mean or calibrated scores were developed for this depression scale through screening of a 
general population. The PROMIS depression short from 8a scale has been used 






 This PROMIS instrument assesses self-reported perception of depression and has 
been widely used and accepted in both the general population and populations with 
chronic illness (Flynn et al., 2015). The Cronbach’s alpha for the depression short form in 
a population of persons with heart failure awaiting transplant was 0.91 and construct 
validity was established by comparing correlations between this PROMIS form and other 
measures of depression (PHQ-2) (Flynn et al., 2015). Additionally, a significant 
correlation was found between administration of the computer-adapted version and the 
short form highlighting the validity of the short form (Flynn et al., 2015). While no 
studies were found that discuss the reliability of PROMIS measures in persons with 
NAFLD, PROMIS depression measures were studied in individuals with liver cirrhosis 
(Bajaj et al., 2011). Lastly, test-retest reliability in persons with cirrhosis identified an 
interclass correlation range from 0.759-0.985 when the PROMIS depression measure was 
administered 12 days apart (Bajaj et al., 2011). 
PROMIS Fatigue Scale 
 The concept of fatigue was measured using the Patient Reported Outcome 
Measurement Information System (PROMIS) fatigue short form 8a. The PROMIS 
fatigue scale assesses fatigue through self-reported symptoms including tiredness, sense 
of exhaustion, frequency, duration, and intensity of fatigue, and the impact of fatigue on 
daily activities (PROMIS Health Organization, 2019b). The PROMIS fatigue short form 
8a is designed for adults over the age of 18, has been universally developed, and is not 
disease specific (PROMIS Health Organization, 2019b).   
 The PROMIS fatigue scale is an 8-item self-reported instrument with a five-point 





2019b). The raw scores on the PROMIS fatigue short form 8a range from 8-40 (PROMIS 
Health Organization, 2019b). The raw scores are converted into T-scores based on a 
conversation table 
(https://www.healthmeasures.net/images/PROMIS/manuals/PROMIS_Fatigue_Scoring_
Manual.pdf). The T-scores of this scale range from 33.1-77.8 with a mean T-score of 50 
and standard deviation of 10 (PROMIS Health Organization, 2019b). This instrument 
assess fatigue over the past 7 days and higher T-score is representative of more severe 
fatigue (PROMIS Health Organization, 2019b). A T-score of 55-60 is considered mild 
fatigue, 60-70 moderate fatigue, and greater than 70 is indicative of severe fatigue 
(PROMIS Health Organization, 2019b). 
 The PROMIS fatigue short form 8a has demonstrated appropriate reliability and 
validity in a variety of patient populations including those with chronic illness 
(Ameringer et al., 2016). A secondary data analysis reviewed the psychometric data of 
the PROMIS fatigue short form 8a in five sample populations of persons with 
fibromyalgia, sickle cell disease, cardiometabolic risk, pregnancy, and healthy controls 
(Ameringer et al., 2016). The Cronbach’s alpha reliability coefficient in these persons 
with chronic illness ranged from .72 to .86  (Ameringer et al., 2016).  Additionally, 
concurrent validity was measured between the PROMIS fatigue scale and the Brief 
Fatigue Inventory (BFI) and correlations ranged from r=.60 to .85. While no studies were 
found that examined the use of the PROMIS fatigue scale in persons with NAFLD, the 
PROMIS fatigue scale demonstrated acceptable reliability, Cronbach alpha > .87 in a 






Exercise Benefits/Barriers Scale 
 Individual perceptions of benefits and barriers to PA were measured using the 
Exercise Benefits/Barriers Scale (Sechrist et al., 1987). The Exercise Benefits/Barriers 
Scale (EBBS) is a 43-item instrument with a four-point Likert scale option ranging from 
“strongly agree” to “strongly disagree” (Sechrist et al., 1987). While the EBBS is one 
instrument, it is subdivided into two subscales including a benefits and a barriers scale 
(Sechrist et al., 1987).  Scores are summed for each subscale to create a total score.  The 
total score for the benefits scale ranges from 29 to 116 and the total score for the barriers 
scale is 14 to 56 (Sechrist et al., 1987). A higher total score indicates an overall positive 
perception of the benefits of PA (Sechrist et al., 1987). All items on the barriers scale 
were reverse coded since subscales were used to better understand both benefits and 
barriers (Sechrist et al., 1987). 
 The standardized Cronbach’s alpha for the EBBS in a northern U.S. general adult 
population was .95 with a test-retest reliability of .89 (Sechrist et al., 1987). The 
Cronbach’s alpha for the 29-item benefit subscale was .954 and the 14-item barriers 
subscale was .866 in the same population (Sechrist et al., 1987). Confirmatory factor 
analysis revealed a two-factor solution that included a benefits and barriers factor 
(Sechrist et al., 1987). Additionally, the EBBS has been used in a young adult cohort. In a 
population of college students, a significant negative correlation was identified between 
benefits and barriers (r = -.46, p<.05) (Brown, 2005). Reliability was confirmed in this 
population of college students with a Cronbach’s alpha of .80 on the barriers subscale and 
.92 on the benefits subscale (Brown, 2005). Although no studies were found in which the 





of chronic illness such as women with osteoarthritis (Shin et al., 2004) persons with HIV 
(Rehm & Konkle-Parker, 2016), and individuals with multiple sclerosis (Stroud et al., 
2009). 
Brief Illness Perception Questionnaire  
 The subjects’ perceptions of severity of illness related to NAFLD were measured 
using the Brief Illness Perception Questionnaire (Brief IPQ) (Broadbent et al., 2006). The 
Brief IPQ is a nine-item instrument established to concisely measure the cognitive and 
emotional response related to a chronic illness (Broadbent et al., 2006). Five of the 
instrument items were developed to assess the cognitive burden of illness, two items 
measure emotional burden of illness, and one item assesses comprehension of illness 
(Broadbent et al., 2006). Each item on the Brief IPQ is assessed on a scale from 0 to 10 
where higher scores are indicative of a stronger perception of the dimension (Broadbent 
et al., 2015). The instrument items assess perceived consequences, timeline, personal 
control, treatment control, identity, concern, and coherence of illness and emotional 
representation (Broadbent et al., 2015).  While each dimension can be examined 
separately, a total score can also be calculated by reverse scoring items 3, 4, and 7 and 
adding these to items 1, 2, 5, 6, and 8.  Total scores can range from 0 to 80 with a higher 
total score reflecting a higher perceived threat of illness (Broadbent et al., 2015). 
The initial psychometric data were tested in six groups of individuals with chronic 
illness including myocardial infarction, renal disease, diabetes, and asthma (Broadbent 
et al., 2006). Concurrent validity was demonstrated through comparing data from the 
Brief IPQ and the previously established IPQ-revised in which 82% of items could be 





Discriminant validity was examined to determine variation of illness perception based on 
disease. As expected, those with more severe chronic illness such as myocardial 
infarction had longer perceived illness timelines than those with reoccurring colds 
(Broadbent et al., 2006). The Brief IPQ has been used in a variety of populations 
including persons with cancer, metabolic disease, mental health disorders, neuromuscular 
disorders, respiratory disease, and infectious disease (Broadbent et al., 2015). The Brief 
IPQ has been used internationally in 36 countries and translated into 26 languages 
(Broadbent et al., 2015).   
Exercise Self-Efficacy Scale  
 Self-efficacy was measured in this study through the use of the Exercise Self-
Efficacy Scale.  The Exercise Self-Efficacy Scale (ESES) is a 10-item instrument that 
measures three components of self-efficacy in subscales including task efficacy, coping 
efficacy, and scheduling efficacy (Rodgers et al., 2002). Each item is scored on a 10-
point Likert scale ranging from “1” (not at all confident) to “10” (completely confident) 
(Rodgers et al., 2002).  A total score is calculated by summing the responses of each item 
with a possible range of scores from 10 to 100 (Rodgers et al., 2002).  A higher total 
ESES score indicates a higher perceived exercise self-efficacy. 
 Initial validation data were collected in a random population of 203 adults 
(Rodgers et al., 2002). Strong internal reliability was demonstrated through a Cronbach 
alpha ranging from .72-.86 for each of the three subscales of the ESES. The reliability of 
the ESES tool was also demonstrated in a general population of adults (n=56) with a 
Cronbach alpha ranging from .77-.89 on the three subscales of the ESES (Rodgers et al., 





self-efficacy scale and included an exploratory factor analysis, confirmatory factor 
analysis, and a 12-week intervention study. In the exploratory factor analysis with a 
sample of 395 undergraduate college students, a direct oblimin technique was used and 
three factors were extracted (task self-efficacy, scheduling self-efficacy, and coping self-
efficacy) (Rogers et al., 2008). A confirmatory factor analysis in sample of 470 
community-based participants yielded an acceptable model supporting the three-factor 
model from the exploratory factor analysis (Rodgers et al., 2008). Lastly, a 12-week 
exercise intervention study in an adult general population was conducted to discern 
whether the ESES observed change in self-efficacy with an increase in activity level 
(Rodgers et al., 2008). All three domains of the ESES demonstrated change over time 
with the exercise intervention indicating that the ESES is an appropriate 
multidimensional tool to assess exercise self-efficacy (Rodgers et al., 2008). 
Concise Physical Activity Questionnaire 
 Level of physical activity was measured by the self-reported Concise Physical 
Activity Questionnaire. The Concise Physical Activity Questionnaire (CPAQ) is a 4-item 
instrument that measures the average self-reported participation in PA per week over the 
past month (Sliter & Sliter, 2014).  CPAQ items measured PA based on intensity and 
include light aerobic, moderate aerobic, vigorous aerobic activity, and muscle-
strengthening activity (Sliter & Sliter, 2014). Response options are scored on a 5-point 
Likert scale including options from “0” (Physically unable/not medically allowed to do 
this or chose not to do this) to 4 (6-7 times per week) (Sliter & Sliter, 2014). A total score 
is calculated by summing the unweighted responses to items 1, 2, and 4 and the weighted 





possible scores on the CPAQ instrument range from 0 to 24 with a higher score indicative 
of more time spent on average in PA per week within a one-month timeframe (Sliter & 
Sliter, 2014). The CPAQ was developed to provide a short, simple, self-report measure of 
PA that would be easy for researchers to score and simple for respondents to complete 
(Sliter & Sliter, 2014). The brevity of the CPAQ instrument is considered a strength in 
this study as the CPAQ is part of a larger battery of study instruments. 
 Initial testing of the validty of the CPAQ was collected in a population of college 
students (Sliter & Sliter, 2014). During initial validation, CPAQ scores were found to be 
inversely correlated with health problems (r = -.19, p < 0.01), BMI (r = -.32, p < 0.001), 
and resting heart rate (r = -.28, p < 0.01) (Sliter & Sliter, 2014). Furthermore, CPAQ 
scores were positively associated with verification of gym attendance (r =.52, p < 0.001) 
(Sliter & Sliter, 2014). The CPAQ has also been utilized in a population of firefighters to 
determine the potential impact of PA on burnout (Sliter & Sliter, 2014). Although the 
CPAQ has not been used in persons with NAFLD, the preliminary findings from this tool 
provide evidence for use of the CPAQ in other populations. 
Demographic Intake Form 
 A structured questionnaire was developed by the investigator to obtain 
demographic data from each study participant. The demographic intake form included 
information regarding age, ethnicity, marital status, employment, disease specific 
characteristics (i.e., duration of NAFLD, pre-cirrhosis vs cirrhosis), rating of current pain 
perception (0-10 scale; no pain to worse pain possible), current prescription medications, 







Data collected during this study were entered into IBM SPSS Statistics software 
version 23.0 for data analysis and interpretation. All data were checked for completeness 
and accuracy by the primary investigator. Frequency distributions were examined to 
identify outliers or potential data entry errors. Statistical significance was determined by 
using an alpha of p < 0.05. Descriptive statistics were used to describe the study 
participants. The first research question listed below was analyzed using a multiple 
regression model. The final research question was analyzed using the PROCESS macro 
function described by Hayes (2009).  This function assesses for mediation between the 
independent and dependent variables. 
1) Do symptoms of fatigue or depression, perceptions of level of illness severity or 
benefits and barriers to physical activity predict the amount of self-reported 
physical activity? 
2) Does exercise self-efficacy mediate the relationship between perceptions of 
benefits or barriers for physical activity and self-report physical activity? 
Summary 
This chapter provided an overview of the cross-sectional correlational study, 
sample, data collection, procedures, human protection strategies, and data analysis.  Data 
collection occurred at the outpatient Piedmont Hepatology and Transplant Clinic in 
Atlanta, GA.  Exclusion and inclusion criteria were set prior to the study conduction and 
all study procedures were approved by both Georgia State and Piedmont Healthcare 
Institutional Review Boards.  An informed consent and HIPAA agreement form were 





collection.  A total of six study instruments and a demographic intake form were 







 The results from this cross-sectional, correlational study examining the 
relationships of fatigue, depression, perceived illness severity, benefits and barriers to 
physical activity on the self-reported level of physical activity are presented in this 
chapter.  A description of the study sample characteristics and findings are included.  
Data were collected between October 2020 and May 2021 at a large hematology and 
transplant clinic in Atlanta, GA. A total of 166 patients, reflected in Figure 2, were 
approached regarding their interest in participating in the study and 34 declined to 
participate.  The remaining 132 patients were screened for eligibility and 19 were 
excluded due to current use of antidepressant medication.  Of the remaining study 
participants, data from three participants were incomplete due to missing greater than 
50% of the data points.  These three participants were excluded from data analysis.  
Participants that used either a cane or walker for mobility (n=12) were also excluded 
from this study. After all exclusions, 98 study participants were included in the data 




















Description of Study Sample 
 Demographic information was collected from study participants and this 
information is summarized in Table 1. The majority of study participants were over the 
age of 50 with ages ranging from 23-75 and the mean age was 58.56 ± 9.1 years.  Forty-
three study participants were male and the remaining 55 were female.  The vast majority 
of study participants were White/Non-Hispanic (n=80), with 16 participants identifying 
as Black/Non-Hispanic, and 2 participants identifying as Hispanic.  A large majority of 
participants completed either a high school diploma or a bachelor’s degree with only 13 
166 patients with NAFLD 
approached 
34 patients declined to participate 
19 patients excluded for current use of 
antidepressant medication 
Data Review 
12 patients excluded due to use of 
mobility devices (i.e. cane/walker) 
n=98 
132 patients screened for 
inclusion/exclusion criteria 






participants with higher levels of education.  Variation in household income was noted 
with a range of less than $20,000 to greater than $100,000 annually. 
Table 1. Study Participant Demographics 
 
Sample Characteristic  n=98 
Sex   
 Male 43 
 Female 55 
Age   
 <39 1 
 30-39 1 
 40-49 12 
 50-59 31 
 60-70 45 
 >70 8 
Ethnicity   
 Black/Non-Hispanic 16 
 Hispanic/Latino 2 
 Non-Hispanic/White 80 
Education   
 High school diploma 35 
 Bachelor’s Degree 50 
 Master’s Degree 8 
 Doctorate Degree 5 
Household Income   
 Less than $20,000 2 
 $20,000-$39,000 12 
 $40,000-$59,000 31 
 $60,000-$79,000 35 
 $80,000-$99,000 11 
 Greater than $100,000 7 
 
 Table 2 demonstrates health demographics surveyed from all study participants 
including body mass index (BMI), length of time since diagnosis, and current level of 
pain. The average BMI of the participants was 32.98 ± 8.90 with a range of 14.64 to 
61.88.  The average duration of the diagnosis of NAFLD was for approximately two and 





months).  Pain was assessed on a numeric scale from 0-10, with the mean pain score of 
0.998 ± 1.995.   
Table 2. Health Demographics for Study Participants 
 
 N Minimum Maximum Mean Std Deviation 
BMI  98 14.64 61.88 32.98 8.90 
Length of time since 
diagnosis of NAFLD 
(months) 
98 6 241 30.32 36.69 
Pain (0-10) 98 0 10 0.998 1.995 
 
Reliability of Study Instruments 
 The internal consistency of all study instruments were analyzed using Cronbach’s 
coefficient alpha.  The coefficient alphas of each instrument are reported in Table 3.  The 
exercise self-efficacy and exercise benefit/barrier scales were analyzed according to their 
separate subscales.  The coefficient alphas of the study instruments ranged from .645 to 
.987 which is indicative of good internal reliability with the exception of the Concise 
Physical Activity Scale (CPAQ).  The Cronbach alpha for the CPAQ scale in this 
population was .505 which is lower than desired.  Initial testing of the CPAQ tool was 
positive, however, this testing was done in a young, healthy population.  The lower alpha 
in this study population is attributed to the chronic nature of NAFLD, which may have 











Table 3. Internal Consistency of Study Instruments 
 
Study Instrument Number 
of Items 
Cronbach Alpha 
PROMIS Fatigue Scale 8 a = .927 
PROMIS Depression Scale 8 a = .987 
Brief Illness Perception Questionnaire 8 a = .645 
Concise Physical Activity Scale 4 a = .505 
Exercise Self Efficacy Scale   
Task Efficacy Subscale 4 a = .706 
Coping Subscale 3 a = .927 
Scheduling Subscale 3 a = .970 
Benefit Subscale 29 a = .951 
Barrier Subscale 14 a = .823 
 
Data Analysis Results 
Descriptive Statistics for Major Study Variables 
 Six study instruments and a demographic intake form were used to collect data 
regarding the variables of interest. Prior to data analysis, a thorough screen of all data for 
data entry errors and missing data was performed.  Additionally, a pre-analysis screen of 
outliers, multicollinearity, homoscedasticity, normality, and linearity was performed.  
Data normality was assessed by analyzing box plots and histograms and no outlying data 
were found.  All variables were normally distributed. Correlations were examined to 
ensure adequate variance in the data set and to assess for multicollinearity between 
independent variables.  Multicollinearity was also assessed by examining the variance 
inflation factor and a Durbin-Watson test was performed to assess for independent errors.  







Table 4. Descriptive Statistics of Study Instruments 
 N Minimum Maximum Mean Std. Deviation 
Depression 98 8 32 11.47 4.73 
Fatigue 98 8 40 19.25 10.18 
Total Barrier Subscale 98 14 42 33.98 4.27 
Total Benefit Subscale 98 29 110 75.60 12.37 
Total Exercise Self-Efficacy 98 10 100 52.48 22.19 
Total Brief Illness Perception 98 4 71 33.68 12.91 
Total Concise Physical 
Activity 
98 0 18 3.60 3.77 
 
Depression 
 Depression was measured using the Patient-Reported Outcomes Measurement 
Information System (PROMIS) depression short form 8a.  Raw scores and total scores 
were analyzed for the study population.  The total scores for this study population ranged 
from 8-32 with a mean depression total score of 11.47 ± 4.73.  In addition to examining 
raw total scores, data were converted to T-scores for review.  Out of all study 
participants, 77 had scores less than 55 and was considered normal, 18 had mild 
depression, 3 with moderate depression, and none with severe depression.  A total of 3 
study participants scored above the cut-off score of 60 and were provided with referral 
information to a psychiatric mental health practitioner for evaluation of depressive 
symptoms. 
Fatigue 
 Fatigue was measured using the Patient Reported Outcome Measurement 





examined for the study population. The total fatigue scores for this population ranged 
from 8-40 with a mean score of 19.25 ± 10.18.  In addition to examining total scores, data 
were converted into T-scores.  Out of all study participants, 60 had PROMIS scores 
indicating a normal response, 12 with mild fatigue, 20 with moderate fatigue, and 6 with 
severe fatigue. 
Exercise Self-Efficacy 
 Individualized self-exercise related to exercise was measures using the Exercise-
Self-Efficacy Scale.  Items were summed to create a total score representing the overall 
perceived exercise self-efficacy.  The total scores of this instrument ranged from 10-100 
with a mean score of 52.48 ± 22.19.  On average, individuals with NAFLD reported a 
moderate level of exercise self-efficacy.  Study participants were most confident that they 
could follow directions from an exercise instructor (mean = 6.44, ± 2.625, but least 
confident that they could exercise when they don’t have time (mean=4.32 ± 2.452). 
Exercise Benefits and Barriers 
 Perceived benefits and barriers to exercise were measured utilizing the Exercise 
Benefits and Barriers scale.  This study instrument is subdivided into two different 
subscales, and data were further examined in benefits and barriers.  A higher score on this 
subscale represents a higher perceived level of barriers to participating in physical 
activity.  The total scores of the barrier scale ranged from 14 to 42 with a mean score of 
33.98 ± 4.27. The highest scoring barrier to exercise was that “exercise tires me” (mean = 
3.15 ± 0.664) and that “I am fatigued by exercise” (mean = 3.14 ± 0.642).  The lowest 
scoring barrier on this scale was that “my spouse does not encourage exercising” (mean = 





score of 75.60  ± 12.37.  Participants felt most strongly that exercise would prevent 
hypertension (mean = 3.05 ± 2.098) and heart attacks (mean = 2.93 ± 0.389).   
Illness Perception 
 The individualized perception of illness was measured through the use of the 
Brief Illness Perception Questionnaire (Brief IPQ).  Study items were summed to 
calculate total scores.  Scores on this study instrument ranged from 4 to 71, with a mean 
score of 33.68 ± 12.91.  Respondents scored the highest on “how concerned are you 
about your illness” (mean 6.48 ± 2.847) and “how long do you believe that your illness 
will continue” (mean = 5.32 ± 2.798).  However, respondents identified that they believe 
that treatment does help their illness (mean 6.48 ± 2.19) and that their overall 
understanding of NAFLD was high. The overall scoring of participants in this study 
indicates that persons with NAFLD perceive a moderately high level of illness (mean = 
33.68 ± 12.92). 
Physical Activity 
 Physical activity was assessed using the Concise Physical Activity Questionnaire.  
A total score was calculated by adding the unweighted responses to question 1, 2, and 4 
and the weighted response to item 3.  Total scores of this study instrument ranged from 0 
to 18 with a mean score of 3.60 ± 3.773.  These data suggests that the individuals with 
NAFLD in this study are relatively inactive. The most common form of physical activity 
was light aerobic activity (mean = 2.80 ± 2.328) and the least common form of physical 
activity was vigorous aerobic activity with only one study participant participating in 





physical activity.  Twenty-five study participants (25.5%) reported participating in no 
regular physical activity.   
Research Question One 
1) Do symptoms of fatigue or depression, perceptions of level of illness severity or 
benefits and barriers to physical activity predict the amount of self-reported 
physical activity? 
A simultaneous multiple linear regression model was used to answer research 
question one using the Enter method in SPSS.  Table 5 provides correlational data for 
independent study variables as a check for multicollinearity.  The variation inflation 
factor (VIF) for each variable is presented in Table 6 and was also used to assess 
multicollinearity. All VIF values for independent variables indicated no multicollinearity. 
The Durbin-Watson statistics for this model was 2.052, thus, meeting the model 
assumption for independent errors and no autocorrection. 
Table 5.  Descriptive & Correlational Data for all Major Study Variables (n=98) 
Variable 1 2 3 4 5 6 7 
1. Barriers ---       
2. Benefits .31** ---      
3. Depression -.11 .27** ---     
4. Fatigue -.11 .45** .41** ---    
5. Physical 
Activity .21** .52** .25** -.31** ---   
6. Exercise Self-
Efficacy -.11 .41** .40** .55** .50** ---  
7. Perceived 









Table 6. Multicollinearity Diagnostics 
Variable 
 






Perceived Illness Severity 1.572 
 
The overall model summary is presented in Table 7. 
Table 7. Linear Regression Model Summary 
 
R R square Adjusted R square 
 
Std. Error of the Estimate 
 





This multiple linear regression model included exercise benefits and barriers, 
depression, fatigue, and illness perception as the independent variables of interest.  A 
multiple linear regression model was calculated to predict physical activity based on the 
independent variables.  A significant regression equation was found with the collective 
module using exercise barriers, exercise benefits, depression, fatigue, perceived illness 
severity, F (5,90) = 14.454, p < .000 with an R2 of .445 and adjusted R2   of .415.  The 
individual predictors were examined more in depth and the exercise benefit (p < .000) 
and barrier scale (p < .000) were the only significant predictors of PA in this model.  







Table 8. Model Coefficients 
 B Coefficient Std. Error 
Standardized 
Coefficients Beta t Sig 
Barriers -.377 .074 -.426 -5.07 .000 
Benefits .184 .029 .599 .480 .000 
Depression -.108 .073 -.136 -1.47 .145 
Fatigue -.024 .036 -.066 -.682 .497 
Illness 
Perception .014 .029 .047 .480 .250 
 
Research Question Two 
2) Does exercise self-efficacy mediate the relationship between perceptions of 
benefits or barriers for physical activity and self-report physical activity? 
To investigate this research question, a mediation analysis was performed using 
PROCESS macro in SPSS.  This PROCESS method described by Hayes (2009) was 
chosen to test this complex model and to assess indirect effect through the proposed 
mediator.  Bootstrapping statistics were used to provide a resampling of datasets to 
provide standard errors, confidence intervals, and to allow for hypothesis testing (Hayes, 
2009).  This analysis utilized a model number 4, confidence interval (CI) of 95%, and 
5000 bootstraps. 
The outcome variable for this analysis was physical activity.  Two mediation models 
were examined using the predictor variables of exercise benefits and exercise barriers and 
the mediation variable was exercise self-efficacy.  The indirect effect was tested using 
non-parametric bootstrapping technique.  In the first model summarized in Figure 3,the 
indirect effect of exercise self-efficacy on exercise barriers and PA did not have a 
statistically significant effect. 
 The indirect effect, summarized in Table 9, was negative (IE -.0460), but non-





exercise barriers and physical activity.  In this model, the lower limit CI was -.0135 and 
the upper limit CI was .002.  Since zero falls within the range of the CI in this model, the 
null hypothesis was maintained. 








Table 9. Indirect Effect of Self-Efficacy on Exercise Barrier and Physical Activity 















A second model shown in Figure 4 was analyzed to determine if there was an 
indirect effect produced by exercise self-efficacy on exercise benefits and level of PA.  
The indirect effect in this model was tested using a non-parametric bootstrapping method.  
This model did produce a statistically significant model in which the indirect effect is 
inferred to be non-zero.  Table 10 demonstrates the indirect effect data which shows the 
lower limit CI was .0172 and the upper limit CI was .0783.  Thus, the indirect effect (IE = 










 b -.14, p = .07 












Table 10. Indirect Effect of Self-Efficacy on Exercise Benefit and Physical Activity 
















Six study instruments and a demographic intake forms were used to collect data 
regarding dependent variables of interest in 98 individuals with nonalcoholic fatty liver 
disease.  Two research questions were developed to examine factors that influence 
physical activity in persons with liver disease.  Additionally, data were collected to 
examine a potential mediation effect of exercise self-efficacy on overall physical activity.  
Data were collected and analyzed through a simultaneous linear regression model.  The 
model was statistically significant and accounted for a total of 41.5% of the total variance 
of the dependent variable.  Perceived benefits and barriers to physical activity was found 
to be statistically significant in this model for predicting physical activity.  Additionally, 
the mediation indirect effect was examined by using a bootstrap model.  Exercise self-
efficacy was not found to cause a significant mediation effect between exercise barriers 
Exercise Self-
Efficacy 





 b  .06, p = .002 





and PA. However, a significant indirect mediating effect of exercise self-efficacy was 







 The purpose of this to chapter is to present the interpretation of the findings 
regarding the effects of perceptions of fatigue, depression, illness severity, exercise 
benefits or barriers on the level of physical activity in individuals with NAFLD. This 
chapter also provides an in-depth review of study findings in relation to existing literature 
and the study framework, study strengths and limitations, implications for clinical 
practice, and suggestions for future research.  The data examined in this research study 
adds to the body of research regarding individuals with non-alcoholic fatty liver disease 
(NAFLD), their perceived symptom burden, and how factors associated with this illness 
may impact their level of physical activity.   
Discussion and Conclusions 
While physical activity has been well-established as a main treatment component 
of NAFLD (Chalassani et al., 2018) there remains a gap in understanding how to best 
improve overall activity level in this population. Data from this study suggest that 
persons with NAFLD are relatively inactive.  Approximately 25% of this current 
population reported participating in no physical activity.  This finding is similar to 
previous findings of PA in persons with NAFLD (Hallsworth et al., 2015; Krasnoff et al., 
2018).  This is clinically significant because PA is a main treatment guideline for persons 
with NAFLD and if not being followed accordingly there is concern for the worsening 





the first study assessing depression, fatigue, illness perception, exercise benefits or 
barriers and the relationship of these variables to physical activity in persons with  
NAFLD.  This study assessed the perceived illness burden, symptomatology, and level of 
activity in an under-researched population and highlights the need for continued work in 
this area. 
Fatigue and Depression 
In this study, the level of fatigue in persons with NAFLD was clinically significant.  
Using the PROMIS fatigue scores, 38 participants had mild, moderate, or severe fatigue 
which is approximately 38% of the study population (n=98).  Data from this study further 
supports current evidence (Assimakopoulos et al., 2018; Dwight et al., 2000; Newton  
et al., 2008) that individuals with NAFLD have high levels of fatigue.  Although fatigue 
was not a significant predictor of PA in this study, previous data suggests that higher 
levels of fatigue were correlated with reduced levels of PA in persons with NAFLD 
(Mlynarsky et al., 2016).   
  In regards to additional symptomatology, there was variability in individual 
reports of depression with approximately a fifth of participants scoring mild or higher on 
the depression rating scale.  Three study participants scored above the cutoff range for the 
depression rating scale, which was indicative of severe depression.  These three 
participants were retained in the study since there had not received any previous 
treatment. However, they were referred for additional screening and possible treatment of 
depressive symptoms.  A growing body of evidence suggest that depression and fatigue 





2018; Dwight et al., 2000; Gerber et al., 2019) and the data from this study helps to 
support this evidence. 
Perceived Illness Severity  
 Perceived illness severity has been well documented as having a significant 
impact on persons with chronic illness (Groarke et al., 2004) and is inversely related with 
level of PA (Zoeckler et al., 2014).  This study further supports this as a negative 
correlation was found between perceived illness severity and level of PA (r = -.29,  
p = .003).  Despite respondents feeling as though treatment plans were helping their 
illness, the overall scoring of participants in this study indicates that persons with 
NAFLD perceive a moderately high level of illness. 
Factors Predicting the Level of Physical Activity 
 Perceptions of depressive symptoms, fatigue, illness severity and benefits or 
barriers were considered as potential factors influencing the current level of PA for 
persons with NAFLD. The overall model demonstrated that 41.5% of the variance of the 
level of PA was explained by the significant, independent variables. Standardized beta 
coefficients were analyzed to better under the strength to which each independent 
variable impacted the dependent variable.  
 Within the model itself, exercise benefits and exercise barriers were the only two 
statistically significant variables predicting physical activity. This suggests that the 
overall perception of benefit of exercise or barriers to exercise best predicted level of 
activity. The perceived benefits of PA were a positive, moderate predictor of level of PA 







Exercise Self-Efficacy as a Potential Mediator of Benefits or Barriers to Physical 
Activity 
 Self-efficacy has been well described as a major determinant of behavioral 
activity change and is defined as the individual’s belief that they can successfully 
implement the proposed behavior change (Bandura, 1977). Improved levels of self-
efficacy have been correlated in prior studies to increased level of PA (Mo et al., 2011). 
Exercise self-efficacy was examined as a potential mediator of the relationships between 
perceived benefits or barriers and the current level of PA.  Additionally, self-efficacy and 
its impact on level of activity has also been studied in many groups of chronic illness 
(Blake et al., 2016, Kasser & Komo, 2012; Zelber-Sagi et al., 2017).  However, there 
have been no studies specifically examining exercise self-efficacy in persons with 
NAFLD.  
 Two mediation models were analyzed to determine if exercise self-efficacy 
mediates the relationship between exercise benefits or barriers and PA.  A bootstrapping 
method was used to assess the role of self-efficacy as a mediator variable between 
exercise benefits or barriers and level of PA.  Bootstrapping generates a multitude of 
samples through random repeated resampling through replacement (Hayes, 2009).  In this 
model, a bootstrapping of 5000 was completed to assess 5000 samples and to create 
confidence intervals to answer the research question.  Bootstrapping methods have had an 
increased use in the past decade due to the use of additional analytical dashboards 
through SPSS.  The MACRO process method was used for this study due to its ability to 





of bootstrapping methods also allows for more generalizability of study data due to the 
resampling of data sets (Hayes, 2009). Although low levels of self-efficacy have been 
described as a potential barrier to level of PA (Craike et al., 2013) the mediation model 
analyzing the indirect effect of exercise self-efficacy on barriers was not statistically 
significant.  Thus, self-efficacy did not mediate the relationship between perceived 
barriers and level of PA. However, the model examining exercise benefits and level of 
PA was significant.  This model suggests that the indirect effect of exercise self-efficacy 
was significant on the effect of exercise benefits and level of PA. This may be attributed 
to self-efficacy being viewed as a benefit of physical activity.  As an example, an 
increased level of exercise-self efficacy, may cause patients to have an increased 
perception of the benefit of PA, thus, increasing level of activity.   
Relationship to Theory 
 This study utilized the theoretical foundation of the Health Belief Model (HBM) 
to examine relationships of study variables.  The HBM is a widely used theory to 
examine factors associated with behavioral changes (Rosenstock, 1974).  The HBM has 
also been widely used to study physical activity as a variable of interest (Hoseini et al., 
2014).  In this study, the concept of perceived threat was measured by assessing the 
perceived illness severity.  Additionally, depression and fatigue were examined as 
potential psychosocial risk factors in this theoretical model.  The concept of benefit of 
action was assessed by the exercise benefits scale and self-efficacy was also examined.  
The underpinnings of this theory easily supported the analysis of study variables in 
relationship to one another.  Despite the theoretical framework, self-efficacy did not 





Also, fatigue and depression were not statistically significant in predicting level of 
physical activity.  Therefore, the research model was only partially supported by study 
findings. 
Limitations of Study 
 Several limitations of this study have been identified.  First, this study utilized a 
convenience sample population.  Although the Piedmont clinic serves a large geographic 
area, study participants were selected from this facility based on convenience for the 
student PI.  This should be evaluated to determine the possible effect of generalizing 
study findings to a larger population.  On average, it took study participants 
approximately twenty minutes to complete all data collection.  A limitation of this study 
would be the respondent burden needed to collect all six study instruments.  While 
exercise benefits/barriers did prove to be a statistically significant finding in this study, 
this questionnaire is lengthy and was skipped completely by three study participants 
presumably due to its length. The reliability of the physical activity instrument used in 
this study is lower than desired.  The concise physical activity questionnaire (CPAQ) was 
chosen due to its brevity and concern for respondent burden.  Initial testing of the CPAQ 
instrument seemed positive, however, the initial psychometric testing was performed in a 
healthy population.  The Cronbach alpha in this study population may be lower due to the 
chronic nature of NAFLD which may change the reliability of this instrument.  Another 
limitation of this study was the self-reported nature of analyzing physical activity.  In 
similar studies, the use of biometric data or step technology have been used.  Self-
reported data was chosen for the use of this study due to funding restrictions.  Due to the 





understanding of their disease process than patients in other more rural areas.  The 
potential impact of this should be considered when assessing for generalizability. Lastly, 
all data collection occurred during the COVID-19 pandemic and researchers should 
examine the possibility of this impacting study results due to gym closures, public health 
concerns in crowded areas such as parks and recreational areas, and government orders 
for quarantine.  The COVID-19 pandemic may have impacted several study variables 
including level of PA, depression, and fatigue. 
Strengths of Study 
 The data collected in this research study has helped to extend the knowledge 
regarding persons with NAFLD and factors that impact their participation in physical 
activity.  Additionally, information regarding symptom burden of those with NAFLD was 
collected to better understand this population as a whole.  This is the first known study to 
examine the relationship between depression, fatigue, exercise benefits and barriers, 
exercise self-efficacy, and perceived illness severity and level of physical activity.  There 
were limited missing data and the study instruments were found to have adequate internal 
reliability.  The study was conducted on the well-established theoretical foundation of the 
Health-Belief Model (HBM).  The HBM was used to assess relationships of study 
variables.  Lastly, a strength of this study was the ability to assess study variables in 
varying degrees of liver illness.  Variability of length of time since onset of illness was 
identified with some participants having been affected for as little as six months and other 
for over 20 years.  Due to the progressive nature of NAFLD, the ability to assess length 





efficacy as a mediator variable instead of a structural variable of the HBM provided an 
innovate approach. 
Implications of Findings on Clinical Practice 
Physical activity is one of the main treatment strategies in managing NAFLD 
(Chalassani et al., 2012).  However, routine guidelines on intensity and duration of 
activity are lacking and the overall level of activity of persons with NAFLD is low.  
Clinical providers should continue to emphasize the importance of physical activity in 
disease treatment and must consider an individualized approach to operationalizing 
physical activity in this diverse population.  Due to the percentage of persons with 
NAFLD experiencing depression and fatigue (Gerber et al., 2019) routine 
recommendations are needed on appropriate screening and treatment guidelines.  NAFLD 
has been described as the hepatic manifestation of metabolic disease and should be 
considered by clinical providers when treating patients with other metabolic disorders.  
Lastly, a better understanding of barriers to physical activity is needed to best guide 
clinical practitioners on how to get their patients to better engage in regular activity.   
Recommendations for Future Research 
 Due to the high prevalence of comorbid NAFLD and fatigue, recommendations of 
future research are needed.  Gerber et al. (2019) suggest the possible inclusion of 
biomarker data in assessing fatigue in individuals with NAFLD.  This could include 
measuring pro-inflammatory cytokines or other objective physical performance markers 
(Gerber et al., 2019). Findings from this research study provide additional details on gaps 
in our current understanding of individuals with NAFLD, their symptom burden, and 





population was relatively inactive, a continued focus on variables associated with poor 
levels of physical activity should be considered.  Additional studies examining physical 
activity using step technology or biometric data should be studied. Due to the current lack 
of guidance on duration, intensity, and frequency of PA in this population of chronic 
illness, future research should be considered to provide guidance. Since the perceived 
benefit of exercise was the only significant predictor of physical activity, planning 
interventional studies on improvement the overall perception of the benefit of activity 
should be considered.  Future studies may benefit from using a different measurement of 
physical activity and should consider using biometric measurements for both fatigue and 
physical activity.  Exercise self-efficacy should be considered in future research to 
promote level of PA in individuals with NAFLD. Additionally, the inclusion of NAFLD 
in metabolic disease studies may be crucial to better understanding overall health in this 
disease continuum. 
Study Summary 
 This study sought to examine the effects of depression, fatigue, perceived illness, 
exercise benefits or barriers on the level of physical activity in individuals with 
nonalcoholic fatty liver disease (NAFLD) and if exercise self-efficacy mediated the 
effects of benefits or barriers on current activity. Data collected from this study provided 
additional evidence to support that persons with NAFLD are not participating in regular 
physical activity.  Data suggest that the overall perceived benefits or barriers of exercise 
were the only study variables that significantly predicted physical activity, with a 
stronger effect related to barriers.  Exercise self-efficacy had a relatively small 





activity in persons with NAFLD.  Greater emphasis is needed on assessing barriers for 
physical activity and identifying strategies for promoting exercise self-efficacy in persons 
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Nonalcoholic Fatty Liver Disease and Factors Influencing Physical Activity 

















Nonalcoholic Fatty Liver Disease and Factors Influencing Physical Activity 
Demographic Intake Form 
 
1. Which of the following best describes your ethnicity/race? (Please check one) 
o Asian/Pacific Islander 
o African American/Black 
o Hispanic/Latino 
o Non-Hispanic/White 
2. What is your highest level of education? (Please check one) 
o Less than high school 
o High School Diploma 
o Bachelor’s Degree 
o Master’s Degree 
o Doctorate Degree 
3. What is the estimated total annual income for your household? (Please select 
one) 





o Greater than $100,000 
4. What is your current level of pain on a scale from 0-10 (ten being the worst pain 
you can imagine)? 
____________________________________________________________ 
5. Do you use any equipment to help move around? (Examples: wheelchair, cane, 
etc.) 



































































































































































The Exercise Benefits/Barriers Scale can be obtained from: 
 
Sechrist, K. R., Walker, S. N., & Pender, N. J.  (1987).  Development and psychometric  
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Concise Physical Activity Questionnaire CPAQ 
Items            
   
Directions 
Please think about the past month. During that time, approximately how many days per week 
did you engage in each of the following types of physical activity for at least 20 consecutive 
minutes? 
 
Example 1. If you walk to work and it takes you 10 minutes each way, that would NOT count 
because the minutes were not consecutive. 
 
Example 2. If you walk to work and it takes you 20 minutes each way, then that would count as 




1. Light aerobic activity (Ex: shopping, housework, leisurely walking) 
2. Moderate aerobic activity (Ex: brisk walking, bicycling, tennis) 
3. Vigorous aerobic activity (Ex: jogging/running, swimming laps, jumping rope) 








































0 1           2           3           4           5           6           7           8           9 10
no affect severely
at all affects my life
 
How long do you think your illness will continue?
0 1           2           3           4           5           6           7           8           9 10
a very forever
short time
How much control do you feel you have over your illness?
0 1           2           3           4           5           6           7           8           9 10
absolutely extreme
no control amount of control
How much do you think your treatment can help your illness?
0 1           2           3           4           5           6           7           8           9 10
not at all extremely
helpful
How much do you experience symptoms from your illness?
0 1           2           3           4           5           6           7           8           9 10
no symptoms many severe
at all symptoms
How concerned are you about your illness?
0 1           2           3           4           5           6           7           8           9 10
not at all extremely
concerned concerned
How well do you feel you understand your illness?




How much does your illness affect your life?
For the following questions, please circle the number that best corresponds to your views:
Brief Illness Perception Questionnaire
doi: 10.1037/t10379-000







Brief Illness Perception Questionnaire
doi: 10.1037/t10379-000
0 1           2           3           4           5           6           7           8           9 10
not at all extremely
affected affected
emotionally emotionally
Please list in rank-order the three most important factors that you believe caused your illness.




How much does your illness affect you emotionally? (e.g. does it make you angry, scared, upset or 
depressed?)





































How confident are you that you can . . .
(1)  pace yourself to avoid overexertion?
(2)  perform all the required movements?
(3)  follow directions from an instructor?
(4)  check how hard your activity is making you work?
Coping
How confident are you that you can exercise when you are . . .
(1)  tired?
(2)  in a bad mood?
(3)  feel you don’t have time?
Scheduling
How confident are you that you could . . .
(1)  overcome obstacles that prevent you from participating regularly?
(2)  make up times you missed?
(3)  exercise regularly no matter what?
Note .  Items were rated on 10-point Likert-type scales anchored with 1 = not at all confident  and 10 = 
completely confident .
Exercise Self-Efficacy Scale
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